BMC BioinformaticsSystems BiologyPeer-reviewed journal article
Empirical methods for the validation of Time-To-Event mathematical models taking into account uncertainty and variability: Application to EGFR+ Lung Adenocarcinoma.
Evgueni JacobiD, Angélique Perrillat-MercerotiD, Jean‐Louis PalgeniD, Adèle L’Hostis, Nicoletta CeresiD, Jean‐Pierre BoisseliD, Jim BosleyiD, Claudio MonteiroiD, Riad KahouliD
Abstract
BackgroundOver the past several decades, metrics have been defined to assess the quality of various types of models and to compare their performance depending on their capacity to explain the variance found in real-life data. However, available validation methods are mostly designed for statistical regressions rather than for mechanistic models. To our knowledge, in the latter case, there are no consensus standards, for instance for the validation of predictions against real-world data given the variability and uncertainty of the data. In this work, we focus on the prediction of time-to-event curves using as an application example a mechanistic model of non-small cell lung cancer. We designed four empirical methods to assess both model performance and reliability of predictions: two methods based on bootstrapped versions of parametric statistical tests: log-rank and combined weighted log-ranks (MaxCombo); and two methods based on bootstrapped prediction intervals, referred to here as raw coverage and the juncture metric. We also introduced the notion of observation time uncertainty to take into consideration the real life delay between the moment when an event happens, and the moment when it is observed and reported. ResultsWe highlight the advantages and disadvantages of these methods according to their application context. We have shown that the context of use of the model has an impact on the model validation process. Thanks to the use of several validation metrics we have highlighted the limit of the model to predict the evolution of the disease in the whole population of mutations at the same time, and that it was more efficient with specific predictions in the target mutation populations. The choice and use of a single metric could have led to an erroneous validation of the model and its context of use. ConclusionsWith this work, we stress the importance of making judicious choices for a metric, and how using a combination of metrics could be more relevant, with the objective of validating a given model and its predictions within a specific context of use. We also show how the reliability of the results depends both on the metric and on the statistical comparisons, and that the conditions of application and the type of available information need to be taken into account to choose the best validation strategy.
- Citations
- 10
- FWCI
- 2.10
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A hybrid mortality prediction model of patients with cavitary pulmonary carcinomas
Maliazurina Binti Saad·bioRxiv·Jun 11, 2018
- Assessing the Operational Feasibility of Evolutionary Therapy in Metastatic Non-Small Cell Lung Cancer
Arina Soboleva, Kailas Shankar Honasoge, … Kateřina Staňková·Journal of Evolutionary BiologyPeer-reviewed·Oct 30, 2026
- An Evaluation of the Efficacy of Preclinical Models of Lung Cancer Drugs
E. Pan, D. Bogumil, … J. Nieva·bioRxiv·Jan 29, 2020
- Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients
- Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer
M. Bilous, C. Serdjebi, … S. Benzekry·bioRxiv·Aug 27, 2019
- Machine learning and mechanistic modeling for prediction of metastatic relapse in breast cancer
C. Nicolo, C. Perier, … S. Benzekry·bioRxiv·Mar 26, 2020